Canada markets open in 5 hours 11 minutes

Evofem Biosciences, Inc. (EVFM)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0788+0.0043 (+5.77%)
At close: 03:58PM EST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
2018-12-31
Total Revenue
15,567
8,244
446
0
0
Cost of Revenue
5,061
4,055
468
-
-
Gross Profit
10,506
4,189
-22
-
-
Operating Expenses
Research Development
35,495
33,129
17,050
22,230
43,415
Selling General and Administrative
109,146
137,861
86,552
30,512
34,227
Total Operating Expenses
144,641
170,990
103,602
52,742
77,642
Operating Income or Loss
-134,135
-166,801
-103,624
-52,742
-77,642
Total Other Income/Expenses Net
-149,328
-38,389
-38,850
-27,745
-48,195
Income Before Tax
-283,454
-205,175
-142,305
-80,029
-125,710
Income Tax Expense
29
17
4
4
2
Income from Continuing Operations
-283,483
-205,192
-142,309
-80,033
-125,712
Net Income
-283,483
-205,192
-142,309
-80,033
-125,712
Net Income available to common shareholders
-282,703
-206,239
-142,309
-80,033
-125,778
Basic EPS
-
-23.70
-31.80
-29.85
-86.10
Diluted EPS
-
-23.70
-31.80
-29.85
-86.10
Basic Average Shares
-
8,727
4,477
2,682
1,460
Diluted Average Shares
-
8,727
4,477
2,682
1,460
EBITDA
-
-165,778
-103,322
-52,479
-77,380